This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Early Winners & Losers

Shares of PeopleSupport (PSPT) jumped in after-hours trading Monday as the outsourcing-services provider beat Wall Street's second-quarter earnings expectation and offered a strong guidance.

PeopleSupport reported earnings of $3.8 million or 20 cents a share, up from $2.2 million, or 12 cents a share, a year ago. Revenue climbed 76% to $25.9 million. Analysts polled by Thomson First Call had expected earnings of 11 cents a share and revenue of $23.7 million.

Looking ahead, the company forecast third-quarter earnings of 13 cents to 15 cents a share, with revenue between $26.2 million and $27 million. Analysts, on average, predict earnings of 11 cents a share and revenue of $24.8 million. For the full year, PeopleSupport expects earnings of 55 cents to 60 cents a share and revenue of $101 million to $103 million. Analysts are looking for earnings of 47 cents a share and revenue of $96.7 million. Shares advanced $1.97, or 15%, to $13.80 in after-hours trading.

Affymetrix (AFFX - Get Report) stumbled after the biotech company swung to a wider-than-expected second-quarter loss. The company recorded a loss of $10.1 million, or 15 cents a share, compared with income of $7.8 million, or 12 cents a share, a year ago. The company's latest-quarter results also include costs for stock options, which were not factored into the year-earlier results. Excluding those costs, Affymetrix would have posted a loss of $6.2 million, or 9 cents a share. Wall Street expected a loss of 1 cent a share. Revenue totaled $80.1 million, down from $84.1 million a year ago and below analysts' target of $88.7 million.

Affymetrix also said that it conducted an internal review of its historical stock-option grant practices from Jan. 1, 1997, through May 31, 2006, and found "certain documentation lapses" from 1997 to 1999. There was one instance where the company determined the option grant date should have been recorded differently. The review, though, didn't indicate any pattern of inappropriately backdating grant dates to provide "discounted" or "in-the-money" grants, Affymetrix said. Shares slipped $1.97, or 9.1%, to $19.60 after hours.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
PWAV $0.06 0.00%
ATRS $2.72 0.00%
AFFX $12.44 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs